Patients with the PAX2 mutation associated with renal hypoplasia will develop end-stage renal disease (ESRD) in almost 100% of cases; therefore, patients with severe kidney malformations associated with ESRD should be tested for mutations of this gene [24]. This evidence concerns the gene PAX2 and chronic kidney disease.